2016 Agenda

Below is a detailed agenda for the Global Cardio-Oncology Summit 2016.

For your convenience, you may also print this agenda.

 

Thursday, September 29, 2016

7:00 am – 6:30 pm

TimeTopicLocation / Speaker
7:00 - 7:50Breakfast & RegistrationRegency A/B/C
7:50 - 8:00Welcome Address & IntroductionCo-Chairs: Christine Simmons, MD & Sean Virani, MD
8:00 - 8:30Cancer and cardiovascular disease: A patient's perspective
Discussion: 10 minutes
TBD
Session 1:
Contemporary Breast Cancer Therapy
Moderators: Susan Dent, MD & Ian Paterson, MD
8:30 - 8:50Are anthracyclines relevant for breast cancer in 2016?Chau T. Dang, MD

Chief, West Harrison Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
8:50 - 9:10Novel Breast Cancer Therapy: Should we have any cardiovascular concerns?Giuseppe Curigliano, MD, PhD

Medical Oncologist, European Institute of Oncology, Milan, Italy
9:10 - 9:30Do cardiovascular preventive strategies work during chemotherapy?Margot Davis, MD

Cardiologist, Vancouver General Hospital & St. Paul's Hospital; Director, Cardio-Oncology Program, University of British Columbia, Vancouver, BC, Canada
9:30 - 10:00Session 1 Case Review & Discussion
How often should we test ejection fraction in cancer patients?
Session 1 Speakers & Case Presenter: Aarti Patel, MD
10:00 - 10:15BreakRegency Foyer
Session 2:
Thrombotic and Vascular Considerations in Patients with Cancer
Moderators: Ana Barac, MD & Michael Mauro, MD
10:15 - 10:35Thrombosis in Cancer Patients: Overall ConsiderationsGary H. Lyman, MD, MPH

Co-Director, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Centre, Seattle, WA, USA
10:35 - 10:55Biology and Pathophysiology of Vascular Effects of Cancer Therapies: How do we measure and monitor?Kevin Croce, MD, PhD

Assistant Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
10:55 - 11:15Novel Oral AnticoagulantsAgnes Lee, MD

Director, Thrombosis Program, Vancouver General Hospital, Vancouver, BC, Canada
11:15 - 11:45Session 2 Case Review & Discussion
Can thrombosis be managed in cancer patients?
Session 2 Speakers & Case Presenter: Sebastian Szmit, MD
11:45 - 1:00LunchRegency D/E/F
Session 3:
Keynote Debate
Moderator: Jean-Bernard Durand, MD
1:00 - 1:40Debate Topic:
Type 1/Type 2 Cardiotoxicity: Is this nonsense?
15-minute presentation & 5-minute rebuttal each
YES: Ronald Witteles, MD

NO: Juan Carlos Plana, MD
1:40 - 2:10Session 3 Case Review & Discussion
What is the aetiology of heart failure in cancer patients?
Session 3 Debaters & Case Presenter: Rupal O'Quinn, MD
Session 4:
Cardiology Imaging
Moderator: Negar Mousavi, MD & Jennifer Liu, MD
2:10 - 2:252D/3D strain imaging and the role of 3D echocardiographyDinesh Thavendiranathan, MD

Cardiologist, Director, Ted Rogers Program in Cardiotoxicity Prevention, Toronto General Hospital, University Health Network, Toronto, ON, Canada
2:25 - 2:40Role of CMR in Cardio-OncologyMark Westwood, MD

Consultant Cardiologist, Barts HEart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK
2:40 - 2:55Role of CT/CAC/Nuclear Imaging in Cardio-OncologyEric Harrison, MD

Director of Advanced Cardiac Imaging, University of South Florida/HCA Memorial Hospital Joint Program, Tampa, FL, USA
2:55 - 3:30Session 4 Case Review & Discussion
How does imaging help the cardio-oncology patients?
Session 4 Speakers & Case Presenter: Michael Fradley, MD
3:30 - 3:45BreakRegency Foyer
Session 5:
Hematology/Oncology - Treatment Modifications to Manage Cardiovascular Toxicity
Moderators: Christine Brezden-Masley, MD & Alexander Lyon, MD
3:45 - 4:05Cardiac Considerations for Plasma Cell DisordersR. Frank Cornell, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Centre, Nashville, TN, USA
4:05 - 4:25Cardiovascular Toxicity in Renal Cell Carcinoma PatientsBernie Eigl, MD

Medical Oncologist, BC Cancer Agency, Vancouver, BC, Canada
4:25 - 4:45Cardiovascular Effects of ADT in Prostate Cancer PatientsChis J. Plummer, MD

Consultant Cardiologist, Freeman Hospital, Newcastle, England
4:45 - 5:15Session 5 Case Review & Discussion
Do cardiac risk factors matter in patients with cancer?
Session 5 Speakers & Case Presenter: Jai Singh, MD
5:15 - 5:20Closing StatementsCo-Chairs: Christine Simmons, MD & Sean Virani, MD
Session 6:
Poster Reception
Evaluators: Giuseppe Curigliano, MD, PhD & Margot Davis, MD
5:20 - 6:30Poster Presentations
Wine and Cheese Reception
6:30Adjourn

Print Agenda

Friday, September 30, 2016

7:00 am – 4:40 pm

TimeTopicLocation / Speaker
Live Stream Presentation Session
7:00 - 7:30BreakfastRegency A/B/C
7:30 - 7:50Cardio-Oncology: Can we make a difference?Daniel Lenihan, MD

Cardiologist, Vanderbilt Heart and Vascular Center, Nashville, TN, USA
7:50 - 8:10Vascular occlusive events with tyrosine kinase inhibitors, other agents - Who, What, Why?Michael Mauro, MD

Leader, Myeloproliferative Neoplasms Program; Attending Physician, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
8:10 - 8:30Live Stream DiscussionSpeakers
8:30 - 8:40Opening Remarks & Day 1 ReviewCo-Chairs: Christine Simmons, MD & Sean Virani, MD
Session 7:
Prevention in Cardio-Oncology
Moderators: Javid Moslehi, MD & Edith Pituskin, PhD, NP
8:40 - 9:00Common Risk Factors Between Cancer and Cardiovascular DiseaseAnne Blaes, MD, MS

Associate Professor of Medicine; Program Director, Cancer Survivor Program, University of Minnesota, Minneapolis, MN, USA
9:00 - 9:20Accelerated Cardiovascular Disease in Cancer Patients and the Cardioprotective Role of ExerciseJessica Scott, PhD

Senior Scientist, Exercise Physiology and Countermeasures, NASA Johnson Space Centre, Universities Space Research Association, Houston, TX, USA
9:20 - 9:40Obesity is a Leading Cause of Cancer DeathPamela Goodwin, MD

Scientist, Samuel Lunenfeld Research Institute; Marvelle Koffler Chair in Breast Research, University of Toronto, Mount Sinai Hospital, Toronto, ON, Canada
9:40 - 10:00Metabolic Issues in Cardio-OncologyPaul Cohen, MD, PhD

Albert Resnick MD, Assistant Professor, Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA
10:00 - 10:30Session 7 Case Review & Discussion
Can we prevent cancer progression by improving cardiac risk factors?
Session 7 Speakers & Case Presenter: Tochi Okwuosa, DO, FACC
10:30 - 10:45BreakRegency Foyer
Session 8: Oral Abstract Presentations
Moderators: Giorgio Minotti, MD & Teresa Lopez-Fernandez, MD
10:45 - 11:00Abstract #1
Discussion: 5 minutes
Kristopher Swiger, MD
Nashville, TN, USA
11:00 - 11:15Abstract #2
Discussion: 5 minutes
Trafina Jadhav, PhD, MS Nashville, TN, USA
11:15 - 11:30Abstract #3
Discussion: 5 minutes
Helena Earl, MBBS Cambridge, Cambridgeshire, UK
11:30 - 12:30LunchRegency D/E/F
Session 9:
Long-Term Management in Primary Care
Moderators: Barbara Fitzgerald, RN & Zaza Iakobishvili, MD, PhD
12:30 - 12:50Pediatric Survivors: The transition to adult cardiovascular medicineLynn Straatman, MD

Pediatric Palliative Care Physician, Canuck Place & BC Children's Hospital, Vancouver, BC, Canada
12:50 - 1:10Long-Term Management: Is there a role for the cardiologist and primary care physician in the community?Nina Ghosh, MD

Director, Cancer Survivorship and Cardiovascular Disease Program, Ottawa Cardiovascular Centre, Ottawa, ON, Canada
1:10 - 1:30Guidelines in Cardio-Oncology: Where are we now?Saro Armenian, DO, MPH

Pediatric Hematologist/ Oncologist; Associate Professor; Director, Childhood Cancer Survivorship Clinic, City of Hope Comprehensive Cancer Center, Duarte, CA
1:30 - 1:50Role of the multidisciplinary team in cardio-oncology: bridging transitions in careEdith Pituskin, PhD, NP

Edmonton, AB, Canada
1:50 - 2:20Session 9 Case Review & Discussion
A cancer survivor in the community
Session 9 Speakers & Case Presenter: Jeffrey Sulpher, MD
Session 10:
Research Frontiers in Cardio-Oncology
Moderator: Javid Moslehi, MD & Laleh Amiri-Kordestani, MD
2:20 - 2:40Regulatory Concerns and Pre-Clinical Testing in Cardio-OncologyKaren Johns, MD MSc

Manager/Health Products and Food Branch, Health Canada, Government of Canada, Ottawa, ON, Canada
2:40 - 3:00NIH/NCI Partnerships and Funding OpportunitiesLori Minasian, MD

Deputy Director, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA
3:00 - 3:20Why children are at risk for cardiotoxicityChristopher Sarosiek, PhD

Instructor in Medicine, Dana-Farber Cancer Institute, Boston, MA, USA
3:20 - 3:50Session 10 Case Review & Discussion
How can science inform clinical practice in cardio-oncology?
Session 10 Speakers & Case Presenter: Brian Jensen, MD
Session 11:
Future Direction
Moderators: Christine Simmons, MD & Sean Virani, MD
3:50 - 4:10Cardio-Oncology Fellowship Training: What does the future hold?
Discussion: 5 minutes
Joseph Carver, MD

Senior Administrative Officer, Abramson Family Cancer Research Institute; Director, Penn Cardiology Fellow's, Abramson Cancer Centre, Philadelphia, PA, USA
4:10 - 4:30Opportunities for collaboration, research & education
Discussion: 5 minutes
Susan Dent, MD & Daniel Lenihan, MD
4:30 - 4:40Closing StatementsCo-Chairs: Christine Simmons, MD & Sean Virani, MD

Print Agenda